Aarkstore - Biomarkers by Shubhangi

AArkstore enterprise 28th November 2014

Aarkstore â&#x20AC;&#x201C; Biomarkers Browse Full Report @ http://www.aarkstore.com/biotechnology/53583/biomarkers Published: Jun 2014 | No. Of Pages: 1303 Pages PDF: $4680 | Global Licence: $9500

Biomarkers Market research report focuses on the different types of biomarkers and their impact on various disease areas such as oncology (prostate, ovarian, breast and lung), neurology (stroke, brain tumor, neurodegenerative diseases), cardiology (coronary heart disease, heart failure, myocardial infarction), infectious diseases (GIT, respiratory tract infections) and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc. The study provides Global Biomarkers market size by the above disease areas and also by prominent biomarker identification technologies including imaging, genomics, proteomics, metabolomics, gene expression and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology. Compilation of Worldwide Patents and Research related to Biomarkers is also provided. Biomarkers Market offers market values for global geographic regions including North America, Europe, Asia-Pacific and Rest of World.

Browse complete Report on: http://www.aarkstore.com/biotechnology/53583/biomarkers

AArkstore enterprise 20% Discount on all RI Technologies Market Research Reports: Click here an avail Discount offer on RI Technologies market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com

Table of Contents: 1. SCOPE AND METHODOLOGY

2. REPORT SYNOPSIS

2.1 Introduction 2.2 Segmentation of Biomarkers Exhibit 1. Segmentation of Global Biomarkers Market by Therapeutic Area and Identification Technology Identification Technologies Imaging Genomics Proteomics

AArkstore enterprise Metabolomics Gene Expression Therapeutic Areas Oncology Cardiology Neurology Infectious Diseases Exhibit 2. Segmentation by Therapeutic Area for Oncology, Cardiology, Neurology, and Infectious Diseases 2.3 Global Biomarkers Market Exhibit 3. Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Billion (Graphical Representation Included) Exhibit 4. List of Global Major Biomarkers Companies

3. MARKET DYNAMICS

3.1 Global Market Overview 3.2 Global Biomarkers Market Exhibit 5. Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 6. Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.3 North American Biomarkers Market

AArkstore enterprise Exhibit 7. Biomarkers - North American Market Estimations & Predictions (2005 -2020) in US$ Million for United States and Canada (Graphical Representation Included) Exhibit 8. Biomarkers - North American Market Shares (2010, 2015 & 2020) for United States and Canada (Graphical Representation Included) 3.3 (I) United States Biomarkers Market 3.3 (II) Canadian Biomarkers Market Exhibit 9. List of North American Biomarkers Companies 3.4 European Biomarkers Market Exhibit 10. Biomarkers - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 11. Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.4 (I) German Biomarkers Market 3.4 (II) United Kingdom Biomarkers Market 3.4 (III) Italian Biomarkers Market 3.4 (IV) French Biomarkers Market 3.4 (V) Spanish Biomarkers Market 3.4 (VI) Swiss Biomarkers Market 3.4 (VII) Belgian Biomarkers Market 3.4 (VIII) Swedish Biomarkers Market 3.4 (IX) Russian Biomarkers Market Exhibit 12. List of European Biomarkers Companies

AArkstore enterprise 3.5 Asia-Pacific Biomarkers Market Exhibit 13. Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 14. Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.5 (I) Japanese Biomarkers Market 3.5 (II) Chinese Biomarkers Market 3.5 (III) Indian Biomarkers Market 3.5 (IV) Australian Biomarkers Market 3.5 (V) South Korean Biomarkers Market Exhibit 15. List of Asia-Pacific Biomarkers Companies 3.6 Rest of World Biomarkers Market Exhibit 16. Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 17. Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.6 (I) Israeli Biomarkers Market 3.6 (II) South African Biomarkers Market 3.6 (III) Brazilian Biomarkers Market Exhibit 18. List of Rest of World Biomarkers Companies 3.7 Market Trends What are Pharma Companies Looking For in Biomarkers? Biomarkers - An Emerging Trend in Pharma Industry

AArkstore enterprise Innovative Biomarker Discovery Methods Aid in Drug Development Stages Biomarkers Becoming Important in Developing Better Drugs Pharma Companies Investing Huge Amounts in Biomarkers Discovery 3.8 Company Profiles - Major Players in Biomarker Market Abbott Diagnostics (USA) Affymetrix, Inc. (USA) Agendia BV ((The Netherlands)) Agilent Technologies, Inc. (USA) AltheaDx, Inc. (USA) Moreâ&#x20AC;Ś. 3.9 Major Activities in Biomarker Industry Exonhit and Pfizer Enters into Research Agreement for AD Biomarkers Identification IVD Acquisition Corporation Takes Over Immucor TcLand Expression Strategic Partnership for Development of Novel RA Biomarkers Stemina Biomarker and Pioneer Hi-Bred Sign Research Agreement Astellas Pharma Completes Acquisition of OSI Pharmaceuticals OriGene and ISB alliance for SRM/MRM database Duke Associates with LabCorp to Develop a Joint Venture Company, the Biomarker Factory Thermo Fisher Enters into a Collaboration Agreement with LCP for Improved Biomarker Discovery and Assay Development Processâ&#x20AC;Ś Axela Associates with Salomao & Zoppi and CRIA Opportunities SQI Diagnostics Enters into a Development Deal with Silliker for Marketing of Botulism Toxin Panel

AArkstore enterprise PROOF Centre Enters into Partnership Agreement with Luminex Celerion Completes Acquisition of MDS Pharma Services Early Stage Clinical Development Operations Philips Signs a MoU with Definiens for Co-Developing and Marketing Solutions for Digital Pathology Ricerca Biosciences LLC Purchases MDS Pharma Services PAREXEL International and Proteome Sciences Forms an Alliance for Biomarker Development Biocartis Acquires Automated DNA/RNA Molecular Diagnostic Testing Platform of Philips Moreâ&#x20AC;Ś. 3.10 Major Product Innovations/Launches in Biomarker Industry AB SCIEX Expands Eksigent Chip Column Family for Nano and Micro LC Proteomics Analysis WaferGen Biosystems Supplies SmartChip Real-Time PCR System to Kyoto University for Enhancing the Research on Regenerative Tissue C-Path Becomes First Ever Biomarker Panel to be Approved by Japanese Regulators Tethys Inc., Receives US Patent for the Outstanding PreDxâ&#x201E;˘ Diabetes Risk Score Test Millipore Launches Test Kits for Human Kidney Damage TGen Piloted Group Led Studies Identify Genetic Links to Kidney Disease WaferGen Biosystems Inc., Markets Two of Gene Expression Profiling Panels Designed for SmartChip Real-Time PCR System Cancer Prevention and Research Institute of Texas Awards Funds to Rules-Based Medicine Quintiles Launches Wide-Ranging Suite of PI3K Biomarker Assays BioMarker Strategies Obtains Funds of US$1 Million from NCI StemTroniX and Power3 Submit Patent Application for Stem Cell Protein Biomarkers

AArkstore enterprise Pronota Achieves Base of Next Generation Sequencing Application for Identification and Quantification of Proteins bioMĂŠrieux and GlaxoSmithKline Enter into Alliance for the Development of Molecular Theranostic Test Moreâ&#x20AC;Ś.. 3.11 Therapeutic Area Analysis Exhibit 19. Biomarkers by Therapeutic Area - Global Market Estimations and Predictions (20052020) in US$ Million for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included) Exhibit 20. Biomarkers - Global Market Shares (2010, 2015 & 2020) for Oncology, Cardiology, Neurology, Infectious Disease, Genetic Disorders & Other (Graphical Representation Included) 3.11.1 ONCOLOGY 3.11.1.1 Global Oncology Biomarkers Market Exhibit 21. Biomarkers in Oncology - Global Market Estimations and Predictions (2005-2020) in US$ Million for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included) Exhibit 22. Biomarkers in Oncology - Global Market Shares (2010, 2015 & 2020) for Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other (Graphical Representation Included) Exhibit 23. Biomarkers in Oncology - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 24. Biomarkers in Oncology - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1.2 North American Oncology Biomarkers Market Exhibit 25. Biomarkers in Oncology - North American Market Estimations and Predictions (20052020) in US$ Million for USA and Canada (Graphical Representation Included)

AArkstore enterprise Exhibit 26. Biomarkers in Oncology - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1.2 (I) United States Oncology Biomarkers Market 3.11.1.2 (II) Canadian Oncology Biomarkers Market Exhibit 27. List of North American Oncology Biomarkers Companies 3.11.1.3 European Oncology Biomarkers Market Exhibit 28. Biomarkers in Oncology - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 29. Biomarkers in Oncology - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.11.1.3 (I) German Oncology Biomarkers Market 3.11.1.3 (II) United Kingdom Oncology Biomarkers Market 3.11.1.3 (III) Italian Oncology Biomarkers Market 3.11.1.3 (IV) French Oncology Biomarkers Market 3.11.1.3 (V) Spanish Oncology Biomarkers Market 3.11.1.3 (VI) Swiss Oncology Biomarkers Market 3.11.1.3 (VII) Belgian Oncology Biomarkers Market 3.11.1.3 (VIII) Swedish Oncology Biomarkers Market 3.11.1.3 (IX) Russian Oncology Biomarkers Market Exhibit 30. List of European Oncology Biomarkers Companies 3.11.1.4 Asia-Pacific Oncology Biomarkers Market

AArkstore enterprise Exhibit 31. Biomarkers in Oncology - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 32. Biomarkers in Oncologyâ&#x20AC;&#x201C; Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1.4 (I) Japanese Oncology Biomarkers Market 3.11.1.4 (II) Chinese Oncology Biomarkers Market 3.11.1.4 (III) Indian Oncology Biomarkers Market 3.11.1.4 (IV) Australian Oncology Biomarkers Market 3.11.1.4 (V) South Korean Oncology Biomarkers Market Exhibit 33. List of Asia-Pacific Oncology Biomarkers Companies 3.11.1.5 Rest of World Oncology Biomarkers Market Exhibit 34. Biomarkers in Oncology - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 35. Biomarkers in Oncology - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1.5 (I) Israeli Oncology Biomarkers Market 3.11.1.5 (II) South African Oncology Biomarkers Market 3.11.1.5 (III) Brazilian Oncology Biomarkers Market Exhibit 36. List of Rest of World Oncology Biomarkers Companies 3.11.1.A PROSTATE CANCER 3.11.1.A .1 Global Prostate Cancer Biomarkers Market

AArkstore enterprise Exhibit 37. Prostate Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 38. Prostate Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1.A .2 North American Prostate Cancer Biomarkers Market Exhibit 39. Prostate Cancer Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 40. Prostate Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1.A .2 (I) United States Prostate Cancer Biomarkers Market 3.11.1.A .2 (II) Canadian Prostate Cancer Biomarkers Market Exhibit 41. List of North American Prostate Cancer Biomarkers Companies 3.11.1.A .3 European Prostate Cancer Biomarkers Market Exhibit 42. Prostate Cancer Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 43. Prostate Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1.A .3 (I) German Prostate Cancer Biomarkers Market 3.11.1.A .3 (II) United Kingdom Prostate Cancer Biomarkers Market 3.11.1.A .3 (III) Italian Prostate Cancer Biomarkers Market 3.11.1.A .3 (IV) French Prostate Cancer Biomarkers Market 3.11.1.A .3 (V) Spanish Prostate Cancer Biomarkers Market

AArkstore enterprise 3.11.1.A .3 (VI) Swiss Prostate Cancer Biomarkers Market 3.11.1.A .3 (VII) Belgian Prostate Cancer Biomarkers Market 3.11.1.A .3 (VIII) Swedish Prostate Cancer Biomarkers Market 3.11.1.A .3 (IX) Russian Prostate Cancer Biomarkers Market Exhibit 44. List of European Prostate Cancer Biomarkers Companies 3.11.1.A .4 Asia-Pacific Prostate Cancer Biomarkers Market Exhibit 45. Prostate Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 46. Prostate Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1.A .4 (I) Japanese Prostate Cancer Biomarkers Market 3.11.1.A .4 (II) Chinese Prostate Cancer Biomarkers Market 3.11.1.A .4 (III) Indian Prostate Cancer Biomarkers Market 3.11.1.A .4 (IV) Australian Prostate Cancer Biomarkers Market 3.11.1.A .4 (V) South Korean Prostate Cancer Biomarkers Market Exhibit 47. List of Asia-Pacific Prostate Cancer Biomarkers Companies 3.11.1.A .5 Rest of World Prostate Cancer Biomarkers Market Exhibit 48. Prostate Cancer Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 49. Prostate Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1.A .5 (I) Israeli Prostate Cancer Biomarkers Market

AArkstore enterprise 3.11.1.A .5 (II) South African Prostate Cancer Biomarkers Market 3.11.1.A .5 (III) Brazilian Prostate Cancer Biomarkers Market 3.11.1. B OVARIAN CANCER 3.11.1.B .1 Global Ovarian Cancer Biomarkers Market Exhibit 50. Ovarian Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 51. Ovarian Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1. B .2 North American Ovarian Cancer Biomarkers Market Exhibit 52. Ovarian Cancer Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 53. Ovarian Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1. B .2 (I) United States Ovarian Cancer Biomarkers Market 3.11.1. B .2 (II) Canadian Ovarian Cancer Biomarkers Market Exhibit 54. List of North American Ovarian Cancer Biomarkers Companies 3.11.1. B .3 European Ovarian Cancer Biomarkers Market Exhibit 55. Ovarian Cancer Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 56. Ovarian Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)

AArkstore enterprise 3.11.1. B .3 (I) German Ovarian Cancer Biomarkers Market 3.11.1. B .3 (II) United Kingdom Ovarian Cancer Biomarkers Market 3.11.1. B .3 (III) Italian Ovarian Cancer Biomarkers Market 3.11.1. B .3 (IV) French Ovarian Cancer Biomarkers Market 3.11.1. B .3 (V) Spanish Ovarian Cancer Biomarkers Market 3.11.1. B .3 (VI) Swiss Ovarian Cancer Biomarkers Market 3.11.1. B .3 (VII) Belgian Ovarian Cancer Biomarkers Market 3.11.1. B .3 (VIII) Swedish Ovarian Cancer Biomarkers Market 3.11.1. B .3 (IX) Russian Ovarian Cancer Biomarkers Market Exhibit 57. List of European Ovarian Cancer Biomarkers Companies 3.11.1. B .4 Asia-Pacific Ovarian Cancer Biomarkers Market Exhibit 58. Ovarian Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 59. Ovarian Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1. B .4 (I) Japanese Ovarian Cancer Biomarkers Market 3.11.1. B .4 (II) Chinese Ovarian Cancer Biomarkers Market 3.11.1. B .4 (III) Indian Ovarian Cancer Biomarkers Market 3.11.1. B .4 (IV) Australian Ovarian Cancer Biomarkers Market 3.11.1. B .4 (V) South Korean Ovarian Cancer Biomarkers Market Exhibit 60. List of Asia-Pacific Ovarian Cancer Biomarkers Companies 3.11.1. B .5 Rest of World Ovarian Cancer Biomarkers Market

AArkstore enterprise Exhibit 61. Ovarian Cancer Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 62. Ovarian Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1. B .5 (I) Israeli Ovarian Cancer Biomarkers Market 3.11.1. B .5 (II) South African Ovarian Cancer Biomarkers Market 3.11.1. B .5 (III) Brazilian Ovarian Cancer Biomarkers Market Exhibit 63. List of Rest of World Ovarian Cancer Biomarkers Companies 3.11.1. C BREAST CANCER 3.11.1. C.1 Global Breast Cancer Biomarkers Market Exhibit 64. Breast Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 65. Breast Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1. C.2 North American Breast Cancer Biomarkers Market Exhibit 66. Breast Cancer Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 67. Breast Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1. C.2 (I) United States Breast Cancer Biomarkers Market 3.11.1. C.2 (II) Canadian Breast Cancer Biomarkers Market Exhibit 68. List of North American Breast Cancer Biomarkers Companies

AArkstore enterprise 3.11.1. C.3 European Breast Cancer Biomarkers Market Exhibit 69. Breast Cancer Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 70. Breast Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1. C.3 (I) German Breast Cancer Biomarkers Market 3.11.1. C.3 (II) United Kingdom Breast Cancer Biomarkers Market 3.11.1. C.3 (III) Italian Breast Cancer Biomarkers Market 3.11.1. C.3 (IV) French Breast Cancer Biomarkers Market 3.11.1. C.3 (V) Spanish Breast Cancer Biomarkers Market 3.11.1. C.3 (VI) Swiss Breast Cancer Biomarkers Market 3.11.1. C.3 (VII) Belgian Breast Cancer Biomarkers Market 3.11.1. C.3 (VIII) Swedish Breast Cancer Biomarkers Market 3.11.1. C.3 (IX) Russian Breast Cancer Biomarkers Market Exhibit 71. List of European Breast Cancer Biomarkers Companies 3.11.1. C.4 Asia-Pacific Breast Cancer Biomarkers Market Exhibit 72. Breast Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 73. Breast Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1. C.4 (I) Japanese Breast Cancer Biomarkers Market

AArkstore enterprise 3.11.1. C.4 (II) Chinese Breast Cancer Biomarkers Market 3.11.1. C.4 (III) Indian Breast Cancer Biomarkers Market 3.11.1. C.4 (IV) Australian Breast Cancer Biomarkers Market 3.11.1. C.4 (V) South Korean Breast Cancer Biomarkers Market Exhibit 74. List of Asia-Pacific Breast Cancer Biomarkers Companies 3.11.1. C.5 Rest of World Breast Cancer Biomarkers Market Exhibit 75. Breast Cancer Biomarkers - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 76. Breast Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1. C.5 (I) Israeli Breast Cancer Biomarkers Market 3.11.1. C.5 (II) South African Breast Cancer Biomarkers Market 3.11.1. C.5 (III) Brazilian Breast Cancer Biomarkers Market Exhibit 77. List of Rest of World Breast Cancer Biomarkers Companies 3.11.1. D LUNG CANCER 3.11.1. D.1 Global Lung Cancer Biomarkers Market Exhibit 78. Lung Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 79. Lung Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1. D.2 North American Lung Cancer Biomarkers Market

AArkstore enterprise Exhibit 80. Lung Cancer Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (20052020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 81. Lung Cancer Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.1. D.2 (I) United States Lung Cancer Biomarkers Market 3.11.1. D.2 (II) Canadian Lung Cancer Biomarkers Market Exhibit 82. List of North American Lung Cancer Biomarkers Companies 3.11.1. D.3 European Lung Cancer Biomarkers Market Exhibit 83. Lung Cancer Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 84. Lung Cancer Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1. D.3 (I) German Lung Cancer Biomarkers Market 3.11.1. D.3 (II) United Kingdom Lung Cancer Biomarkers Market 3.11.1. D.3 (III) Italian Lung Cancer Biomarkers Market 3.11.1. D.3 (IV) French Lung Cancer Biomarkers Market 3.11.1. D.3 (V) Spanish Lung Cancer Biomarkers Market 3.11.1. D.3 (VI) Swiss Lung Cancer Biomarkers Market 3.11.1. D.3 (VII) Belgian Lung Cancer Biomarkers Market 3.11.1. D.3 (VIII) Swedish Lung Cancer Biomarkers Market 3.11.1. D.3 (IX) Russian Lung Cancer Biomarkers Market Exhibit 85. List of European Lung Cancer Biomarkers Companies

AArkstore enterprise 3.11.1. D.4 Asia-Pacific Lung Cancer Biomarkers Market Exhibit 86. Lung Cancer Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 87. Lung Cancer Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1. D.4 (I) Japanese Lung Cancer Biomarkers Market 3.11.1. D.4 (II) Chinese Lung Cancer Biomarkers Market 3.11.1. D.4 (III) Indian Lung Cancer Biomarkers Market 3.11.1. D.4 (IV) Australian Lung Cancer Biomarkers Market 3.11.1. D.4 (V) South Korean Lung Cancer Biomarkers Market Exhibit 88. List of Asia-Pacific Lung Cancer Biomarkers Companies 3.11.1. D.5 Rest of World Lung Cancer Biomarkers Market Exhibit 89. Lung Cancer Biomarkers - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 90. Lung Cancer Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.1. D.5 (I) Israeli Lung Cancer Biomarkers Market 3.11.1. D.5 (II) South African Lung Cancer Biomarkers Market 3.11.1. D.5 (III) Brazilian Lung Cancer Biomarkers Market Exhibit 91. List of Rest of World Lung Cancer Biomarkers Companies 3.11.1. E OTHER CANCERS 3.11.1. E.1 Global Other Cancer Biomarkers Market

AArkstore enterprise Exhibit 92. Other Cancer Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 93. Other Cancer Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.1. E.2 North American Other Cancers Biomarkers Market Exhibit 94. Other Cancers Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 95. Other Cancers Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) Exhibit 96. List of North American Other Cancers Biomarkers Companies 3.11.1. E.3 European Other Cancers Biomarkers Market Exhibit 97. Other Cancers Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 98. Other Cancers Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.1. E.4 Asia-Pacific Other Cancers Biomarkers Market Exhibit 99. Other Cancers Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 100. Other Cancers Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.1. E.5 Rest of World Other Cancers Biomarkers Market

AArkstore enterprise Exhibit 101. Other Cancers Biomarkers - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 102. Other Cancers Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.2 CARDIOLOGY 3.11.2.1 Global Cardiology Biomarkers Market Exhibit 103. Biomarkers in Cardiology - Global Market Estimations and Predictions (2005-2020) in US$ Million for Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical Representation Included) Exhibit 104. Biomarkers in Cardiology - Global Market Shares (2010, 2015 & 2020) for Coronary Heart Disease, Heart Failure, Myocardial Infarction and Other (Graphical Representation Included) Exhibit 105. Biomarkers in Cardiology - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 106. Biomarkers in Cardiology - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.2.2 North American Cardiology Biomarkers Market Exhibit 107. Biomarkers in Cardiology - North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 108. Biomarkers in Cardiology - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.2.2 (I) United States Cardiology Biomarkers Market 3.11.2.2 (II)Canadian Cardiology Biomarkers Market Exhibit 109. List of North American Cardiology Biomarkers Companies 3.11.2.3 European Cardiology Biomarkers Market

AArkstore enterprise Exhibit 110. Biomarkers in Cardiology - European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 111. Biomarkers in Cardiology - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.11.2.3 (I) German Cardiology Biomarkers Market 3.11.2.3 (II) United Kingdom Cardiology Biomarkers Market 3.11.2.3 (III) Italian Cardiology Biomarkers Market 3.11.2.3 (IV) French Cardiology Biomarkers Market 3.11.2.3 (V) Spanish Cardiology Biomarkers Market 3.11.2.3 (VI) Swiss Cardiology Biomarkers Market 3.11.2.3 (VII) Belgian Cardiology Biomarkers Market 3.11.2.3 (VIII) Swedish Cardiology Biomarkers Market 3.11.2.3 (IX) Russian Cardiology Biomarkers Market

List Of Tables

Exhibit 112. List of European Cardiology Biomarkers Companies 3.11.2.4 Asia-Pacific Cardiology Biomarkers Market

AArkstore enterprise Exhibit 113. Biomarkers in Cardiology - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 114. Biomarkers in Cardiologyâ&#x20AC;&#x201C; Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.2.4 (I) Japanese Cardiology Biomarkers Market 3.11.2.4 (II) Chinese Cardiology Biomarkers Market 3.11.2.4 (III) Indian Cardiology Biomarkers Market 3.11.2.4 (IV) Australian Cardiology Biomarkers Market 3.11.2.4 (V) South Korean Cardiology Biomarkers Market Exhibit 115. List of Asia-Pacific Cardiology Biomarkers Companies 3.11.2.5 Rest of World Cardiology Biomarkers Market Exhibit 116. Biomarkers in Cardiology - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 117. Biomarkers in Cardiology - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.2.5 (I) Israeli Cardiology Biomarkers Market 3.11.2.5 (II) South African Cardiology Biomarkers Market 3.11.2.5 (III) Brazilian Cardiology Biomarkers Market Exhibit 118. List of Rest of World Cardiology Biomarkers Companies 3.11.2.A CORONARY HEART DISEASE 3.11.2.A.1 Global Coronary Heart Disease Biomarkers Market

AArkstore enterprise Exhibit 119. Coronary Heart Disease Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 120. Coronary Heart Disease Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.2.A.2 North American Coronary Heart Disease Biomarkers Market Exhibit 121. Coronary Heart Disease Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 122. Coronary Heart Disease Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.2.A.2 (I) United States Coronary Heart Disease Biomarkers Market 3.11.2.A.2 (II) Canadian Coronary Heart Disease Biomarkers Market Exhibit 123. List of North American Coronary Heart Disease Biomarkers Companies 3.11.2.A.3 European Coronary Heart Disease Biomarkers Market Exhibit 124. Coronary Heart Disease Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 125. Coronary Heart Disease Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.2.A.3 (I) German Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (II) United Kingdom Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (III) Italian Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (IV) French Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (V) Spanish Coronary Heart Disease Biomarkers Market

AArkstore enterprise 3.11.2.A.3 (VI) Swiss Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (VII) Belgian Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (VIII) Swedish Coronary Heart Disease Biomarkers Market 3.11.2.A.3 (IX) Russian Coronary Heart Disease Biomarkers Market Exhibit 126. List of European Coronary Heart Disease Biomarkers Companies 3.11.2.A.4 Asia-Pacific Coronary Heart Disease Biomarkers Market Exhibit 127. Coronary Heart Disease Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 128. Coronary Heart Disease Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.2.A.4 (I) Japanese Coronary Heart Disease Biomarkers Market 3.11.2.A.4 (II) Chinese Coronary Heart Disease Biomarkers Market 3.11.2.A.4 (III) Indian Coronary Heart Disease Biomarkers Market 3.11.2.A.4 (IV) Australian Coronary Heart Disease Biomarkers Market 3.11.2.A.4 (V) South Korean Coronary Heart Disease Biomarkers Market Exhibit 129. List of Asia-Pacific Coronary Heart Disease Biomarkers Companies 3.11.2.A.5 Rest of World Coronary Heart Disease Biomarkers Market Exhibit 130. Coronary Heart Disease Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 131. Coronary Heart Disease Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)

AArkstore enterprise 3.11.2.A.5 (I) Israeli Coronary Heart Disease Biomarkers Market 3.11.2.A.5 (II) South African Coronary Heart Disease Biomarkers Market 3.11.2.A.5 (III) Brazilian Coronary Heart Disease Biomarkers Market Exhibit 132. List of Rest of World Coronary Heart Disease Biomarkers Companies 3.11.2.B HEART FAILURE 3.11.2.B.1 Global Heart Failure Biomarkers Market Exhibit 133. Heart Failure Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 134. Heart Failure Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.2.B.2 North American Heart Failure Biomarkers Market Exhibit 135. Heart Failure Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 136. Heart Failure Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.2.B.2 (I) United States Heart Failure Biomarkers Market 3.11.2.B.2 (II) Canadian Heart Failure Biomarkers Market Exhibit 137. List of North American Heart Failure Biomarkers Companies 3.11.2.B.3 European Heart Failure Biomarkers Market Exhibit 138. Heart Failure Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)

AArkstore enterprise Exhibit 139. Heart Failure Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.2.B.3 (I) German Heart Failure Biomarkers Market 3.11.2.B.3 (II) United Kingdom Heart Failure Biomarkers Market 3.11.2.B.3 (III) Italian Heart Failure Biomarkers Market 3.11.2.B.3 (IV) French Heart Failure Biomarkers Market 3.11.2.B.3 (V) Spanish Heart Failure Biomarkers Market 3.11.2.B.3 (VI) Swiss Heart Failure Biomarkers Market 3.11.2.B.3 (VII) Belgian Heart Failure Biomarkers Market 3.11.2.B.3 (VIII) Swedish Heart Failure Biomarkers Market 3.11.2.B.3 (IX) Russian Heart Failure Biomarkers Market Exhibit 140. List of European Heart Failure Biomarkers Companies 3.11.2.B.4 Asia-Pacific Heart Failure Biomarkers Market Exhibit 141. Heart Failure Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 142. Heart Failure Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.2.B.4 (I) Japanese Heart Failure Biomarkers Market 3.11.2.B.4 (II) Chinese Heart Failure Biomarkers Market 3.11.2.B.4 (III) Indian Heart Failure Biomarkers Market 3.11.2.B.4 (IV) Australian Heart Failure Biomarkers Market 3.11.2.B.4 (V) South Korean Heart Failure Biomarkers Market

AArkstore enterprise Exhibit 143. List of Asia-Pacific Heart Failure Biomarkers Companies 3.11.2.B.5 Rest of World Heart Failure Biomarkers Market Exhibit 144. Heart Failure Biomarkers - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 145. Heart Failure Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.2.B.5 (I) Israeli Heart Failure Biomarkers Market 3.11.2.B.5 (II) South African Heart Failure Biomarkers Market 3.11.2.B.5 (III) Brazilian Heart Failure Biomarkers Market Exhibit 146. List of Rest of World Heart Failure Biomarkers Companies 3.11.2.C MYOCARDIAL INFARCTION 3.11.2.C.1 Global Myocardial Infarction Biomarkers Market Exhibit 147. Myocardial Infarction Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 148. Myocardial Infarction Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.2.C.2 North American Myocardial Infarction Biomarkers Market Exhibit 149. Myocardial Infarction Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 150. Myocardial Infarction Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.2.C.2 (I) United States Myocardial Infarction Biomarkers Market 3.11.2.C.2 (II) Canadian Myocardial Infarction Biomarkers Market

AArkstore enterprise Exhibit 151. List of North American Myocardial Infarction Biomarkers Companies 3.11.2.C.3 European Myocardial Infarction Biomarkers Market Exhibit 152. Myocardial Infarction Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 153. Myocardial Infarction Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.2.C.3 (I) German Myocardial Infarction Biomarkers Market 3.11.2.C.3 (II) United Kingdom Myocardial Infarction Biomarkers Market 3.11.2.C.3 (III) Italian Myocardial Infarction Biomarkers Market 3.11.2.C.3 (IV) French Myocardial Infarction Biomarkers Market 3.11.2.C.3 (V) Spanish Myocardial Infarction Biomarkers Market 3.11.2.C.3 (VI) Swiss Myocardial Infarction Biomarkers Market 3.11.2.C.3 (VII) Belgian Myocardial Infarction Biomarkers Market 3.11.2.C.3 (VIII) Swedish Myocardial Infarction Biomarkers Market 3.11.2.C.3 (IX) Russian Myocardial Infarction Biomarkers Market Exhibit 154. List of European Myocardial Infarction Biomarkers Companies 3.11.2.C.4 Asia-Pacific Myocardial Infarction Biomarkers Market Exhibit 155. Myocardial Infarction Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 156. Myocardial Infarction Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)

AArkstore enterprise 3.11.2.C.4 (I) Japanese Myocardial Infarction Biomarkers Market 3.11.2.C.4 (II) Chinese Myocardial Infarction Biomarkers Market 3.11.2.C.4 (III) Indian Myocardial Infarction Biomarkers Market 3.11.2.C.4 (IV) Australian Myocardial Infarction Biomarkers Market 3.11.2.C.4 (V) South Korean Myocardial Infarction Biomarkers Market Exhibit 157. List of Asia-Pacific Myocardial Infarction Biomarkers Companies 3.11.2.C.5 Rest of World Myocardial Infarction Biomarkers Market Exhibit 158. Myocardial Infarction Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 159. Myocardial Infarction Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.2.C.5 (I) Israeli Myocardial Infarction Biomarkers Market 3.11.2.C.5 (II) South African Myocardial Infarction Biomarkers Market 3.11.2.C.5 (III) Brazilian Myocardial Infarction Biomarkers Market Exhibit 160. List of Rest of World Myocardial Infarction Biomarkers Companies 3.11.2.D OTHER CARDIAC BIOMARKERS 3.11.2.D.1 Global Other Cardiac Biomarkers Market Exhibit 161. Other Cardiac Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 162. Other Cardiac Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.2.D.2 North American Other Cardiac Biomarkers Market

AArkstore enterprise Exhibit 163. Other Cardiac Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 164. Other Cardiac Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.2.D.3 European Other Cardiac Biomarkers Market Exhibit 165. Other Cardiac Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 166. Other Cardiac Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.2.D.4 Asia-Pacific Other Cardiac Biomarkers Market Exhibit 167. Other Cardiac Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 168. Other Cardiac Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.2.D.5 Rest of World Other Cardiac Biomarkers Market Exhibit 169. Other Cardiac Biomarkers - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 170. Other Cardiac Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.3 NEUROLOGY 3.11.3.1 Global Neurology Biomarkers Market

AArkstore enterprise Exhibit 171. Biomarkers in Neurology- Global Market Estimations and Predictions (2005-2020) in US$ Million or Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation Included) Exhibit 172. Biomarkers in Neurology- Global Market Shares (2010, 2015 & 2020) for Stroke, Brain Tumor, Neurodegenerative Disorders and Other (Graphical Representation Included) Exhibit 173. Biomarkers in Neurology - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 174. Biomarkers in Neurology - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.3.2 North American Neurology Biomarkers Market Exhibit 175. Biomarkers in Neurology - North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 176. Biomarkers in Neurology - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.3.2 (I) United States Neurology Biomarkers Market 3.11.3.2 (II) Canadian Neurology Biomarkers Market Exhibit 177. List of North American Neurology Biomarkers Companies 3.11.3.3 European Neurology Biomarkers Market Exhibit 178. Biomarkers in Neurology - European Market Estimations and Predictions (20052020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 179. Biomarkers in Neurology - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.11.3.3 (I) German Neurology Biomarkers Market

AArkstore enterprise 3.11.3.3 (II) United Kingdom Neurology Biomarkers Market 3.11.3.3 (III) Italian Neurology Biomarkers Market 3.11.3.3 (IV) French Neurology Biomarkers Market 3.11.3.3 (V) Spanish Neurology Biomarkers Market 3.11.3.3 (VI) Swiss Neurology Biomarkers Market 3.11.3.3 (VII) Belgian Neurology Biomarkers Market 3.11.3.3 (VIII) Swedish Neurology Biomarkers Market 3.11.3.3 (IX) Russian Neurology Biomarkers Market Exhibit 180. List of European Neurology Biomarkers Companies 3.11.3.4 Asia-Pacific Neurology Biomarkers Market Exhibit 181. Biomarkers in Neurology - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 182. Biomarkers in Neurology - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.3.4 (I) Japanese Neurology Biomarkers Market 3.11.3. 4 (II) Chinese Neurology Biomarkers Market 3.11.3. 4 (III) Indian Neurology Biomarkers Market 3.11.3. 4 (IV) Australian Neurology Biomarkers Market 3.11.3. 4 (V) South Korean Neurology Biomarkers Market Exhibit 183. List of Asia-Pacific Neurology Biomarkers Companies 3.11.3.5 Rest of World Neurology Biomarkers Market

AArkstore enterprise Exhibit 184. Biomarkers in Neurology - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 185. Biomarkers in Neurology - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.3.5 (I) Israeli Neurology Biomarkers Market 3.11.3. 5 (II) South African Neurology Biomarkers Market 3.11.3. 5 (III) Brazilian Neurology Biomarkers Market Exhibit 186. List of Rest of World Neurology Biomarkers Companies 3.11.3.A STROKE 3.11.3.A.1 Global Stroke Biomarkers Market Exhibit 187. Stroke Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 188. Stroke Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.3.A.2 North American Stroke Biomarkers Market Exhibit 189. Stroke Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 190. Stroke Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.3.A.2 (I) United States Stroke Biomarkers Market 3.11.3.A.2 (II) Canadian Stroke Biomarkers Market Exhibit 191. List of North American Stroke Biomarkers Companies 3.11.3.A.3 European Stroke Biomarkers Market

AArkstore enterprise Exhibit 192. Stroke Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 193. Stroke Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.3.A.3 (I) German Stroke Biomarkers Market 3.11.3.A.3 (II) United Kingdom Stroke Biomarkers Market 3.11.3.A.3 (III) Italian Stroke Biomarkers Market 3.11.3.A.3 (IV) French Stroke Biomarkers Market 3.11.3.A.3 (V) Spanish Stroke Biomarkers Market 3.11.3.A.3 (VI) Swiss Stroke Biomarkers Market 3.11.3.A.3 (VII) Belgian Stroke Biomarkers Market 3.11.3.A.3 (VIII) Swedish Stroke Biomarkers Market 3.11.3.A.3 (IX) Russian Stroke Biomarkers Market Exhibit 194. List of European Stroke Biomarkers Companies 3.11.3.A.4 Asia-Pacific Stroke Biomarkers Market Exhibit 195. Stroke Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 196. Stroke Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.3.A.4 (I) Japanese Stroke Biomarkers Market 3.11.3.A.4 (II) Chinese Stroke Biomarkers Market

AArkstore enterprise 3.11.3.A.4 (III) Indian Stroke Biomarkers Market 3.11.3.A.4 (IV) Australian Stroke Biomarkers Market 3.11.3.A.4 (V) South Korean Stroke Biomarkers Market Exhibit 197. List of Asia-Pacific Stroke Biomarkers Companies 3.11.3.A.5 Rest of World Stroke Biomarkers Market Exhibit 198. Stroke Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 199. Stroke Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.3.A.5 (I) Israeli Stroke Biomarkers Market 3.11.3.A.5 (II) South African Stroke Biomarkers Market 3.11.3.A.5 (III) Brazilian Stroke Biomarkers Market Exhibit 200. List of Rest of World Stroke Biomarkers Companies 3.11.3.B BRAIN TUMOR 3.11.3.B.1 Global Brain Tumor Biomarkers Market Exhibit 201. Brain Tumor Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 202. Brain Tumor Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.3.B.2 North American Brain Tumor Biomarkers Market Exhibit 203. Brain Tumor Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)

AArkstore enterprise Exhibit 204. Brain Tumor Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.3.B.2 (I) United States Brain Tumor Biomarkers Market 3.11.3.B.2 (II) Canadian Brain Tumor Biomarkers Market Exhibit 205. List of North American Brain Tumor Biomarkers Companies 3.11.3.B.3 European Brain Tumor Biomarkers Market Exhibit 206. Brain Tumor Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 207. Brain Tumor Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.3.B.3 (I) German Brain Tumor Biomarkers Market 3.11.3.B.3 (II) United Kingdom Brain Tumor Biomarkers Market 3.11.3.B.3 (III) Italian Brain Tumor Biomarkers Market 3.11.3.B.3 (IV) French Brain Tumor Biomarkers Market 3.11.3.B.3 (V) Spanish Brain Tumor Biomarkers Market 3.11.3.B.3 (VI) Swiss Brain Tumor Biomarkers Market 3.11.3.B.3 (VII) Belgian Brain Tumor Biomarkers Market 3.11.3.B.3 (VIII) Swedish Brain Tumor Biomarkers Market 3.11.3.B.3 (IX) Russian Brain Tumor Biomarkers Market Exhibit 208. List of European Brain Tumor Biomarkers Companies 3.11.3.B.4 Asia-Pacific Brain Tumor Biomarkers Market

AArkstore enterprise Exhibit 209. Brain Tumor Biomarkers - Asia-Pacific Market Estimations and Predictions (20052020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 210. Brain Tumor Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.3.B.4 (I) Japanese Brain Tumor Biomarkers Market 3.11.3.B.4 (II) Chinese Brain Tumor Biomarkers Market 3.11.3.B.4 (III) Indian Brain Tumor Biomarkers Market 3.11.3.B.4 (IV) Australian Brain Tumor Biomarkers Market 3.11.3.B.4 (V) South Korean Brain Tumor Biomarkers Market Exhibit 211. List of Asia-Pacific Brain Tumor Biomarkers Companies 3.11.3.B.5 Rest of World Brain Tumor Biomarkers Market Exhibit 212. Brain Tumor Biomarkers - Rest of World Market Estimations and Predictions (20052020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 213. Brain Tumor Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.3.B.5 (I) Israeli Brain Tumor Biomarkers Market 3.11.3.B.5 (II) South African Brain Tumor Biomarkers Market 3.11.3.B.5 (III) Brazilian Brain Tumor Biomarkers Market Exhibit 214. List of Rest of World Brain Tumor Biomarkers Companies 3.11.3.C NEURODEGENERATIVE DISEASES 3.11.3.C.1 Global Neurodegenerative Diseases Biomarkers Market

AArkstore enterprise Exhibit 215. Neurodegenerative Diseases Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 216. Neurodegenerative Diseases Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.3.C.2 North American Neurodegenerative Diseases Biomarkers Market Exhibit 217. Neurodegenerative Diseases Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (20052020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 218. Neurodegenerative Diseases Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.3.C.2 (I) United States Neurodegenerative Diseases Biomarkers Market 3.11.3.C.2 (II) Canadian Neurodegenerative Diseases Biomarkers Market Exhibit 219. List of North American Neurodegenerative Diseases Biomarkers Companies 3.11.3.C.3 European Neurodegenerative Diseases Biomarkers Market Exhibit 220. Neurodegenerative Diseases Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 221. Neurodegenerative Diseases Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.3.C.3 (I) German Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (II) United Kingdom Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (III) Italian Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (IV) French Neurodegenerative Diseases Biomarkers Market

AArkstore enterprise 3.11.3.C.3 (V) Spanish Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (VI) Swiss Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (VII) Belgian Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (VIII) Swedish Neurodegenerative Diseases Biomarkers Market 3.11.3.C.3 (IX) Russian Neurodegenerative Diseases Biomarkers Market Exhibit 222. List of European Neurodegenerative Diseases Biomarkers Companies 3.11.3.C.4 Asia-Pacific Neurodegenerative Diseases Biomarkers Market Exhibit 223. Neurodegenerative Diseases Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 224. Neurodegenerative Diseases Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.3.C.4 (I) Japanese Neurodegenerative Diseases Biomarkers Market 3.11.3.C.4 (II) Chinese Neurodegenerative Diseases Biomarkers Market 3.11.3.C.4 (III) Indian Neurodegenerative Diseases Biomarkers Market 3.11.3.C.4 (IV) Australian Neurodegenerative Diseases Biomarkers Market 3.11.3.C.4 (V) South Korean Neurodegenerative Diseases Biomarkers Market Exhibit 225. List of Asia-Pacific Neurodegenerative Diseases Biomarkers Companies 3.11.3.C.5 Rest of World Neurodegenerative Diseases Biomarkers Market Exhibit 226. Neurodegenerative Diseases Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)

AArkstore enterprise Exhibit 227. Neurodegenerative Diseases Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.3.C.5 (I) Israeli Neurodegenerative Diseases Biomarkers Market 3.11.3.C.5 (II) South African Neurodegenerative Diseases Biomarkers Market 3.11.3.C.5 (III) Brazilian Neurodegenerative Diseases Biomarkers Market Exhibit 228. List of Rest of World Neurodegenerative Diseases Biomarkers Companies 3.11.3.D OTHER NEUROLOGICAL DISORDERS 3.11.3.D.1 Global Other Neurological Disorder Biomarkers Market Exhibit 229. Other Neurological Disorder Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 230. Other Neurological Disorder Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.3.D.2 North American Other Neurological Disorder Biomarkers Market Exhibit 231. Other Neurological Disorder Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 232. Other Neurological Disorder Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.3.D.3 European Other Neurological Disorder Biomarkers Market Exhibit 233. Other Neurological Disorder Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)

AArkstore enterprise Exhibit 234. Other Neurological Disorder Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.3.D.4 Asia-Pacific Other Neurological Disorder Biomarkers Market Exhibit 235. Other Neurological Disorder Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 236. Other Neurological Disorder Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.3.D.5 Rest of World Other Neurological Disorder Biomarkers Market Exhibit 237. Other Neurological Disorder Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 238. Other Neurological Disorder Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.4 INFECTIOUS DISEASES 3.11.4.1 Global Infectious Diseasesâ&#x20AC;&#x2122; Biomarkers Market Exhibit 239. Biomarkers for Infectious Diseases- Global Market Estimations and Predictions (2005-2020) in US$ Million for GIT, Respiratory Tract infections and Other (Graphical Representation Included) Exhibit 240. Biomarkers for Infectious Diseases- Global Market Shares (2010, 2015 & 2020) for GIT, Respiratory Tract infections and Other (Graphical Representation Included) Exhibit 241. Biomarkers for Infectious Diseases - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

AArkstore enterprise Exhibit 242. Biomarkers for Infectious Diseases - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.4.2 North American Infectious Diseases’ Biomarkers Market Exhibit 243. Biomarkers for Infectious Diseases - North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 244. Biomarkers for Infectious Diseases - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.4.2 (I) United States Infectious Diseases’ Biomarkers Market 3.11.4.2 (II) Canadian Infectious Diseases’ Biomarkers Market Exhibit 245. List of North American Infectious Diseases’ Biomarkers Companies 3.11.4.3 European Infectious Diseases’ Biomarkers Market Exhibit 246. Biomarkers for Infectious Diseases - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 247. Biomarkers for Infectious Diseases - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.11.4.3 (I) German Infectious Diseases’ Biomarkers Market 3.11.4.3 (II) United Kingdom Infectious Diseases’ Biomarkers Market 3.11.4.3 (III) Italian Infectious Diseases’ Biomarkers Market 3.11.4.3 (IV) French Infectious Diseases’ Biomarkers Market 3.11.4.3 (V) Spanish Infectious Diseases’ Biomarkers Market 3.11.4.3 (VI) Swiss Infectious Diseases’ Biomarkers Market 3.11.4.3 (VII) Belgian Infectious Diseases’ Biomarkers Market

AArkstore enterprise 3.11.4.3 (VIII) Swedish Infectious Diseases’ Biomarkers Market 3.11.4.3 (IX) Russian Infectious Diseases’ Biomarkers Market Exhibit 248. List of European Infectious Diseases’ Biomarkers Companies 3.11.4.4 Asia-Pacific Infectious Diseases’ Biomarkers Market Exhibit 249. Biomarkers for Infectious Diseases - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 250. Biomarkers for Infectious Diseases - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.4.4 (I) Japanese Infectious Diseases’ Biomarkers Market 3.11.4.4 (II) Chinese Infectious Diseases’ Biomarkers Market 3.11.4.4 (III) Indian Infectious Diseases’ Biomarkers Market 3.11.4.4 (IV) Australian Infectious Diseases’ Biomarkers Market 3.11.4.4 (V) South Korean Infectious Diseases’ Biomarkers Market Exhibit 251. List of Asia-Pacific Infectious Diseases’ Biomarkers Companies 3.11.4.5 Rest of World Infectious Diseases’ Biomarkers Market Exhibit 252. Biomarkers for Infectious Diseases - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 253. Biomarkers for Infectious Diseases - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.4.5 (I) Israeli Infectious Diseases’ Biomarkers Market 3.11.4.5 (II) South African Infectious Diseases’ Biomarkers Market

AArkstore enterprise 3.11.4.5 (III) Brazilian Infectious Diseases’ Biomarkers Market Exhibit 254. List of Rest of World Infectious Diseases’ Biomarkers Companies 3.11.4.A GASTROINTESTINAL TRACT INFECTIONS (GIT) 3.11.4.A.1 Global Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 255. Gastrointestinal Tract Infection (GIT) Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 256. Gastrointestinal Tract Infection (GIT) Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.4.A.2 North American Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 257. Gastrointestinal Tract Infection (GIT) Biomarkers– North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 258. Gastrointestinal Tract Infection (GIT) Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.4.A.2 (I) United States Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.2 (II) Canadian Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 259. List of North American Gastrointestinal Tract Infection (GIT) Biomarkers Companies 3.11.4.A.3 European Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 260. Gastrointestinal Tract Infection (GIT) Biomarkers– European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 261. Gastrointestinal Tract Infection (GIT) Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included)

AArkstore enterprise 3.11.4.A.3 (I) German Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (II) United Kingdom Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (III) Italian Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (IV) French Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (V) Spanish Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (VI) Swiss Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (VII) Belgian Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (VIII) Swedish Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.3 (IX) Russian Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 262. List of European Gastrointestinal Tract Infection (GIT) Biomarkers Companies 3.11.4.A.4 Asia-Pacific Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 263. Gastrointestinal Tract Infection (GIT) Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 264. Gastrointestinal Tract Infection (GIT) Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.4.A.4 (I) Japanese Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.4 (II) Chinese Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.4 (III) Indian Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.4 (IV) Australian Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.4 (V) South Korean Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 265. List of Asia-Pacific Gastrointestinal Tract Infection (GIT) Biomarkers Companies

AArkstore enterprise 3.11.4.A.5 Rest of World Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 266. Gastrointestinal Tract Infection (GIT) Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 267. Gastrointestinal Tract Infection (GIT) Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.4.A.5 (I) Israeli Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.5 (II) South African Gastrointestinal Tract Infection (GIT) Biomarkers Market 3.11.4.A.5 (III) Brazilian Gastrointestinal Tract Infection (GIT) Biomarkers Market Exhibit 268. List of Rest of World Gastrointestinal Tract Infection (GIT) Biomarkers Companies 3.11.4.B RESPIRATORY TRACT INFECTIONS 3.11.4.B.1 Global Respiratory Tract Infection Biomarkers Market Exhibit 269. Respiratory Tract Infection Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 270. Respiratory Tract Infection Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.4.B.2 North American Respiratory Tract Infection Biomarkers Market

List of Figures

Exhibit 271. Respiratory Tract Infection Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included)

AArkstore enterprise Exhibit 272. Respiratory Tract Infection Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.4.B.2 (I) United States Respiratory Tract Infection Biomarkers Market 3.11.4.B.2 (II) Canadian Respiratory Tract Infection Biomarkers Market Exhibit 273. List of North American Respiratory Tract Infection Biomarkers Companies 3.11.4.B.3 European Respiratory Tract Infection Biomarkers Market Exhibit 274. Respiratory Tract Infection Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 275. Respiratory Tract Infection Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.4.B.3 (I) German Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (II) United Kingdom Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (III) Italian Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (IV) French Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (V) Spanish Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (VI) Swiss Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (VII) Belgian Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (VIII) Swedish Respiratory Tract Infection Biomarkers Market 3.11.4.B.3 (IX) Russian Respiratory Tract Infection Biomarkers Market Exhibit 276. List of European Respiratory Tract Infection Biomarkers Companies 3.11.4.B.4 Asia-Pacific Respiratory Tract Infection Biomarkers Market

AArkstore enterprise Exhibit 277. Respiratory Tract Infection Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 278. Respiratory Tract Infection Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.4.B.4 (I) Japanese Respiratory Tract Infection Biomarkers Market 3.11.4.B.4 (II) Chinese Respiratory Tract Infection Biomarkers Market 3.11.4.B.4 (III) Indian Respiratory Tract Infection Biomarkers Market 3.11.4.B.4 (IV) Australian Respiratory Tract Infection Biomarkers Market 3.11.4.B.4 (V) South Korean Respiratory Tract Infection Biomarkers Market Exhibit 279. List of Asia-Pacific Respiratory Tract Infection Biomarkers Companies 3.11.4.B.5 Rest of World Respiratory Tract Infection Biomarkers Market Exhibit 280. Respiratory Tract Infection Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 281. Gastrointestinal Tract Infection (GIT) Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.4.B.5 (I) Israeli Respiratory Tract Infection Biomarkers Market 3.11.4.B.5 (II) South African Respiratory Tract Infection Biomarkers Market 3.11.4.B.5 (III) Brazilian Respiratory Tract Infection Biomarkers Market Exhibit 282. List of Rest of World Respiratory Tract Infection Biomarkers Companies 3.11.4.C OTHER INFECTIOUS DISEASES 3.11.4.C.1 Global Other Infectious Disease Biomarkers Market

AArkstore enterprise Exhibit 283. Other Infectious Disease Biomarkers - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 284. Other Infectious Disease Biomarkers - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.4.C.2 North American Other Infectious Disease Biomarkers Market Exhibit 285. Other Infectious Disease Biomarkersâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 286. Other Infectious Disease Biomarkers - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.4.C.3 European Other Infectious Disease Biomarkers Market Exhibit 287. Other Infectious Disease Biomarkersâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 288. Other Infectious Disease Biomarkers - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.11.4.C.4 Asia-Pacific Other Infectious Disease Biomarkers Market Exhibit 289. Other Infectious Disease Biomarkers - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 290. Other Infectious Disease Biomarkers - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.4.C.5 Rest of World Other Infectious Disease Biomarkers Market

AArkstore enterprise Exhibit 291. Other Infectious Disease Biomarkers - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 292. Other Infectious Disease Biomarkers - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.5 GENETIC DISORDERS 3.11.5.1 Global Genetic Disorders’ Biomarkers Market Exhibit 293. Biomarkers for Genetic Disorders - Global Market Estimations and Predictions (20052020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 294. Biomarkers for Genetic Disorders - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.5.2 North American Genetic Disorders’ Biomarkers Market Exhibit 295. Biomarkers for Genetic Disorders - North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 296. Biomarkers for Genetic Disorders - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.5.2 (I) United States Genetic Disorders’ Biomarkers Market 3.11.5.2 (II) Canadian Genetic Disorders’ Biomarkers Market Exhibit 297. List of North American Genetic Disorders’ Biomarkers Companies 3.11.5.3 European Genetic Disorders’ Biomarkers Market Exhibit 298. Biomarkers for Genetic Disorders - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included)

AArkstore enterprise Exhibit 299. Biomarkers for Genetic Disorders - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.11.5.3 (I) German Genetic Disorders’ Biomarkers Market 3.11.5.3 (II) United Kingdom Genetic Disorders’ Biomarkers Market 3.11.5.3 (III) Italian Genetic Disorders’ Biomarkers Market 3.11.5.3 (IV) French Genetic Disorders’ Biomarkers Market 3.11.5.3 (V) Spanish Genetic Disorders’ Biomarkers Market 3.11.5.3 (VI) Swiss Genetic Disorders’ Biomarkers Market 3.11.5.3 (VII) Belgian Genetic Disorders’ Biomarkers Market 3.11.5.3 (VIII) Swedish Genetic Disorders’ Biomarkers Market 3.11.5.3 (IX) Russian Genetic Disorders’ Biomarkers Market Exhibit 300. List of European Genetic Disorders’ Biomarkers Companies 3.11.5.4 Asia-Pacific Genetic Disorders’ Biomarkers Market Exhibit 301. Biomarkers for Genetic Disorders - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 302. Biomarkers for Genetic Disorders - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.11.5.4 (I) Japanese Genetic Disorders’ Biomarkers Market 3.11.5.4 (II) Chinese Genetic Disorders’ Biomarkers Market 3.11.5.4 (III) Indian Genetic Disorders’ Biomarkers Market 3.11.5.4 (IV) Australian Genetic Disorders’ Biomarkers Market

AArkstore enterprise 3.11.5.4 (V) South Korean Genetic Disorders’ Biomarkers Market Exhibit 303. List of Asia-Pacific Genetic Disorders’ Biomarkers Companies 3.11.5.5 Rest of World Genetic Disorders’ Biomarkers Market Exhibit 304. Biomarkers for Genetic Disorders - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 305. Biomarkers for Genetic Disorders - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.11.5.5 (I) Israeli Genetic Disorders’ Biomarkers Market 3.11.5.5 (II) South African Genetic Disorders’ Biomarkers Market 3.11.5.5 (III) Brazilian Genetic Disorders’ Biomarkers Market Exhibit 306. List of Rest of World Genetic Disorders’ Biomarkers Companies 3.11.6 OTHER THREAPUTIC AREAS 3.11.6.1 Global Biomarkers Market for Other Therapeutic Areas Exhibit 307. Biomarkers for Other Therapeutic Areas - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 308. Biomarkers for Other Therapeutic Areas - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.11.6.2 North American Biomarkers Market for Other Therapeutic Areas Exhibit 309. Biomarkers for Other Therapeutic Areas - North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 310. Biomarkers for Other Therapeutic Areas - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.11.6.3 European Biomarkers Market for Other Therapeutic Areas

AArkstore enterprise Exhibit 311. Biomarkers for Other Therapeutic Areas - European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 312. Biomarkers for Other Therapeutic Areas - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) 3.11.6.4 Asia-Pacific Biomarkers Market for Other Therapeutic Areas Exhibit 313. Biomarkers for Other Therapeutic Areas - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 314. Biomarkers for Other Therapeutic Areas - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 315. Biomarkers for Other Therapeutic Areas - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million in US$ Million (Graphical Representation Included) Exhibit 316. Biomarkers for Other Therapeutic Areas - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.12 Biomarker Identification Technology Analysis by Geographic Region Exhibit 317. Biomarkers by Identification Technology - Global Market Estimations and Predictions (2005-2020) in US$ Million for Imaging, Genomics, Proteomics, Metabolomics, Gene Expression & Other (Graphical Representation Included) Exhibit 318. Biomarkers - Global Market Shares (2010, 2015 & 2020) for Imaging, Genomics, Proteomics, Metabolomics, Gene Expression & Other (Graphical Representation Included) 3.12.1 IMAGING 3.12.1.1 Global Biomarkers Imaging Technologies Market

AArkstore enterprise Exhibit 319. Imaging Technologies for Biomarker Identification - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 320. Imaging Technologies for Biomarker Identification - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.12.1.2 North American Biomarkers Imaging Technologies Market Exhibit 321. Imaging Technologies for Biomarker Identificationâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 322. Imaging Technologies for Biomarker Identification - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.12.1.2 (I) United States Biomarkers Imaging Technologies Market 3.12.1.2 (II) Canadian Biomarkers Imaging Technologies Market Exhibit 323. List of North American Biomarkers Imaging Technologies Companies 3.12.1.3 European Biomarkers Imaging Technologies Market Exhibit 324. Imaging Technologies for Biomarker Identificationâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 325. Imaging Technologies for Biomarker Identification - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.12.1.3 (I) German Biomarkers Imaging Technologies Market 3.12.1.3 (II) United Kingdom Imaging Technologies Market 3.12.1.3 (III) Italian Biomarkers Imaging Technologies Market

AArkstore enterprise 3.12.1.3 (IV) French Biomarkers Imaging Technologies Market 3.12.1.3 (V) Spanish Biomarkers Imaging Technologies Market 3.12.1.3 (VI) Swiss Biomarkers Imaging Technologies Market 3.12.1.3 (VII) Belgian Biomarkers Imaging Technologies Market 3.12.1.3 (VIII) Swedish Biomarkers Imaging Technologies Market 3.12.1.3 (IX) Russian Biomarkers Imaging Technologies Market Exhibit 326. List of European Biomarkers Imaging Technologies Companies 3.12.1.4 Asia-Pacific Biomarkers Imaging Technologies Market Exhibit 327. Imaging Technologies for Biomarker Identification - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 328. Imaging Technologies for Biomarker Identification - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.12.1.4 (I) Japanese Biomarkers Imaging Technologies Market 3.12.1.4 (II) Chinese Biomarkers Imaging Technologies Market 3.12.1.4 (III) Indian Biomarkers Imaging Technologies Market 3.12.1.4 (IV) Australian Biomarkers Imaging Technologies Market 3.12.1.4 (V) South Korean Biomarkers Imaging Technologies Market Exhibit 329. List of Asia-Pacific Biomarkers Imaging Technologies Companies 3.12.1.5 Rest of World Biomarkers Imaging Technologies Market Exhibit 330. Imaging Technologies for Biomarker Identification - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included)

AArkstore enterprise Exhibit 331. Imaging Technologies for Biomarker Identification - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.12.1.5 (I) Israeli Biomarkers Imaging Technologies Market 3.12.1.5 (II) South African Biomarkers Imaging Technologies Market 3.12.1.5 (III) Brazilian Biomarkers Imaging Technologies Market Exhibit 332. List of Rest of World Biomarkers Imaging Technologies Companies 3.12.2 GENOMICS 3.12.2.1 Global Biomarkers Genomic Technologies Market Exhibit 333. Genomic Technologies for Biomarker Identification - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 334. Genomic Technologies for Biomarker Identification - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.12.2.2 North American Biomarkers Genomic Technologies Market Exhibit 335. Genomic Technologies for Biomarker Identificationâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 336. Genomic Technologies for Biomarker Identification - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.12 .2.2 (I) United States Biomarkers Genomic Technologies Market 3.12.2.2 (II) Canadian Biomarkers Genomic Technologies Market Exhibit 337. List of North American Biomarkers Genomic Technologies Companies 3.12.2.3 European Biomarkers Genomic Technologies Market

AArkstore enterprise Exhibit 338. Genomic Technologies for Biomarker Identificationâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 339. Genomic Technologies for Biomarker Identification - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.12.2.3 (I) German Biomarkers Genomic Technologies Market 3.12.2.3 (II) United Kingdom Genomic Technologies Market 3.12.2.3 (III) Italian Biomarkers Genomic Technologies Market 3.12.2.3 (IV) French Biomarkers Genomic Technologies Market 3.12 .2.3 (V) Spanish Biomarkers Genomic Technologies Market 3.12.2.3 (VI) Swiss Biomarkers Genomic Technologies Market 3.12.2.3 (VII) Belgian Biomarkers Genomic Technologies Market 3.12.2.3 (VIII) Swedish Biomarkers Genomic Technologies Market 3.12.2.3 (IX) Russian Biomarkers Genomic Technologies Market Exhibit 340. List of European Biomarkers Genomic Technologies Companies 3.12.2.4 Asia-Pacific Biomarkers Genomic Technologies Market Exhibit 341. Genomic Technologies for Biomarker Identification - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 342. Genomic Technologies for Biomarker Identification - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.12.2.4 (I) Japanese Biomarkers Genomic Technologies Market

AArkstore enterprise 3.12.2.4 (II) Chinese Biomarkers Genomic Technologies Market 3.12.2.4 (III) Indian Biomarkers Genomic Technologies Market 3.12.2.4 (IV) Australian Biomarkers Genomic Technologies Market 3.12.2.4 (V) South Korean Biomarkers Genomic Technologies Market Exhibit 343. List of Asia-Pacific Biomarkers Genomic Technologies Companies 3.12.2.5 Rest of World Biomarkers Genomic Technologies Market Exhibit 344. Genomic Technologies for Biomarker Identification - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 345. Genomic Technologies for Biomarker Identification - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.12.2.5 (I) Israeli Biomarkers Genomic Technologies Market 3.12.2.5 (II) South African Biomarkers Genomic Technologies Market 3.12.2.5 (III) Brazilian Biomarkers Genomic Technologies Market Exhibit 346. List of Rest of World Biomarkers Genomic Technologies Companies 3.12.3 PROTEOMICS 3.12.3.1 Global Biomarkers Proteomic Technologies Market Exhibit 347. Proteomic Technologies for Biomarker Identification - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 348. Proteomic Technologies for Biomarker Identification - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.12.3.2 North American Biomarkers Proteomic Technologies Market

AArkstore enterprise Exhibit 349. Proteomic Technologies for Biomarker Identificationâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 350. Proteomic Technologies for Biomarker Identification - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.12.3.2 (I) United States Biomarkers Proteomic Technologies Market 3.12.3.2 (II) Canadian Biomarkers Proteomic Technologies Market Exhibit 351. List of North American Biomarkers Proteomic Technologies Companies 3.12.3.3 European Biomarkers Proteomic Technologies Market Exhibit 352. Proteomic Technologies for Biomarker Identificationâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 353. Proteomic Technologies for Biomarker Identification - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.12.3.3 (I) German Biomarkers Proteomic Technologies Market 3.12 .3.3 (II) United Kingdom Proteomic Technologies Market 3.12.3.3 (III) Italian Biomarkers Proteomic Technologies Market 3.12.3.3 (IV) French Biomarkers Proteomic Technologies Market 3.12.3.3 (I) Spanish Biomarkers Proteomic Technologies Market 3.12.3.3 (VI) Swiss Biomarkers Proteomic Technologies Market 3.12.3.3 (VII) Belgian Biomarkers Proteomic Technologies Market 3.12.3.3 (VIII) Swedish Biomarkers Proteomic Technologies Market 3.12.3.3 (IX) Russian Biomarkers Proteomic Technologies Market

AArkstore enterprise Exhibit 354. List of European Biomarkers Proteomic Technologies Companies 3.12.3.4 Asia-Pacific Biomarkers Proteomic Technologies Market Exhibit 355. Proteomic Technologies for Biomarker Identification - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 356. Proteomic Technologies for Biomarker Identification - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.12.3.4 (I) Japanese Biomarkers Proteomic Technologies Market 3.12.3.4 (II) Chinese Biomarkers Proteomic Technologies Market 3.12.3.4 (III) Indian Biomarkers Proteomic Technologies Market 3.12.3.4 (IV) Australian Biomarkers Proteomic Technologies Market 3.12.3.4 (V) South Korean Biomarkers Proteomic Technologies Market Exhibit 357. List of Asia-Pacific Biomarkers Proteomic Technologies Companies 3.12.3.5 Rest of World Biomarkers Proteomic Technologies Market Exhibit 358. Proteomic Technologies for Biomarker Identification - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 359. Proteomic Technologies for Biomarker Identification - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.12.3.5 (I) Israeli Biomarkers Proteomic Technologies Market 3.12.3.5 (II) South African Biomarkers Proteomic Technologies Market 3.12.3.5 (III) Brazilian Biomarkers Proteomic Technologies Market Exhibit 360. List of Rest of World Biomarkers Proteomic Technologies Companies

AArkstore enterprise 3.12.4 METABOLOMICS 3.12.4.1 Global Biomarkers Metabolomics Technologies Market Exhibit 361. Metabolomics Technologies for Biomarker Identification - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 362. Metabolomics Technologies for Biomarker Identification - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.12.4.2 North American Biomarkers Metabolomics Technologies Market Exhibit 363. Metabolomics Technologies for Biomarker Identificationâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 364. Metabolomics Technologies for Biomarker Identification - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.12.4.2 (I) United States Biomarkers Metabolomics Technologies Market 3.12.4.2 (II) Canadian Biomarkers Metabolomics Technologies Market Exhibit 365. List of North American Biomarkers Metabolomics Technologies Companies 3.12.4.3 European Biomarkers Metabolomics Technologies Market Exhibit 366. Metabolomics Technologies for Biomarker Identificationâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 367. Metabolomics Technologies for Biomarker Identification - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.12.4.3 (I) German Biomarkers Metabolomics Technologies Market 3.12.4.3 (II) United Kingdom Metabolomics Technologies Market

AArkstore enterprise 3.12.4.3 (III) Italian Biomarkers Metabolomics Technologies Market 3.12.4.3 (IV) French Biomarkers Metabolomics Technologies Market 3.12.4.3 (V) Spanish Biomarkers Metabolomics Technologies Market 3.12.4.3 (VI) Swiss Biomarkers Metabolomics Technologies Market 3.12.4.3 (VII) Belgian Biomarkers Metabolomics Technologies Market 3.12.4.3 (VIII) Swedish Biomarkers Metabolomics Technologies Market 3.12.4.3 (IX) Russian Biomarkers Metabolomics Technologies Market Exhibit 368. List of European Biomarkers Metabolomics Technologies Companies 3.12.4.4 Asia-Pacific Biomarkers Metabolomics Technologies Market Exhibit 369. Metabolomics Technologies for Biomarker Identification - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 370. Metabolomics Technologies for Biomarker Identification - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.12.4.4 (I) Japanese Biomarkers Metabolomics Technologies Market 3.12.4.4 (II) Chinese Biomarkers Metabolomics Technologies Market 3.12.4.4 (III) Indian Biomarkers Metabolomics Technologies Market 3.12.4.4 (IV) Australian Biomarkers Metabolomics Technologies Market 3.12.4.4 (V) South Korean Biomarkers Metabolomics Technologies Market Exhibit 371. List of Asia-Pacific Biomarkers Metabolomics Technologies Companies 3.12.4.5 Rest of World Biomarkers Metabolomics Technologies Market

AArkstore enterprise Exhibit 372. Metabolomics Technologies for Biomarker Identification - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 373. Metabolomics Technologies for Biomarker Identification - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.12.4.5 (I) Israeli Biomarkers Metabolomics Technologies Market 3.12.4.5 (II) South African Biomarkers Metabolomics Technologies Market 3.12.4.5 (III) Brazilian Biomarkers Metabolomics Technologies Market Exhibit 374. List of Rest of World Biomarkers Metabolomics Technologies Companies 3.12.5.GENE EXPRESSION 3.12.5.1Global Biomarkers Gene Expression Technologies Market Exhibit 375. Gene Expression Technologies for Biomarker Identification - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 376. Gene Expression Technologies for Biomarker Identification - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) 3.12.5.2 North American Biomarkers Gene Expression Technologies Market Exhibit 377. Gene Expression Technologies for Biomarker Identificationâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 378. Gene Expression Technologies for Biomarker Identification - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.12.5.2 (I) United States Biomarkers Gene Expression Technologies Market 3.12.5.2 (II) Canadian Biomarkers Gene Expression Technologies Market

AArkstore enterprise Exhibit 379. List of North American Biomarkers Gene Expression Technologies Companies 3.12.5.3 European Biomarkers Gene Expression Technologies Market Exhibit 380. Gene Expression Technologies for Biomarker Identificationâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 381. Gene Expression Technologies for Biomarker Identification - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.12.5.3 (I) German Biomarkers Gene Expression Technologies Market 3.12.5.3 (II) United Kingdom Gene Expression Technologies Market 3.12.5.3 (III) Italian Biomarkers Gene Expression Technologies Market 3.12.5.3 (IV) French Biomarkers Gene Expression Technologies Market 3.12.5.3 (V) Spanish Biomarkers Gene Expression Technologies Market 3.12.5.3 (VI) Swiss Biomarkers Gene Expression Technologies Market 3.12.5.3 (VII) Belgian Biomarkers Gene Expression Technologies Market 3.12.5.3 (VIII) Swedish Biomarkers Gene Expression Technologies Market 3.12.5.3 (IX) Russian Biomarkers Gene Expression Technologies Market Exhibit 382. List of European Biomarkers Gene Expression Technologies Companies 3.12.5.4 Asia-Pacific Biomarkers Gene Expression Technologies Market Exhibit 383. Gene Expression Technologies for Biomarker Identification - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) Exhibit 384. Gene Expression Technologies for Biomarker Identification - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included)

AArkstore enterprise 3.12.5.4 (I) Japanese Biomarkers Gene Expression Technologies Market 3.12.5.4 (II) Chinese Biomarkers Gene Expression Technologies Market 3.12.5.4 (III) Indian Biomarkers Gene Expression Technologies Market 3.12.5.4 (IV) Australian Biomarkers Gene Expression Technologies Market 3.12.5.4 (V) South Korean Biomarkers Gene Expression Technologies Market Exhibit 385. List of Asia-Pacific Biomarkers Gene Expression Technologies Companies 3.12.5.5 Rest of World Biomarkers Gene Expression Technologies Market Exhibit 386. Gene Expression Technologies for Biomarker Identification - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 387. Gene Expression Technologies for Biomarker Identification - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included) 3.12.5.5 (I) Israeli Biomarkers Gene Expression Technologies Market 3.12.5.5 (II) South African Biomarkers Gene Expression Technologies Market 3.12.5.5 (III) Brazilian Biomarkers Gene Expression Technologies Market Exhibit 388. List of Rest of World Biomarkers Gene Expression Technologies Companies 3.12.6 OTHER IDENTIFICATION TECHNOLOGIES 3.12.6.1 Global Other Biomarkers Identification Technologies Market Exhibit 389. Other Biomarkers Identification Technologies - Global Market Estimations and Predictions (2005-2020) in US$ Million for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included) Exhibit 390. Other Biomarkers Identification Technologies - Global Market Shares (2010, 2015 & 2020) for North America, Europe, Asia-Pacific and Rest of World (Graphical Representation Included)

AArkstore enterprise 3.12.6.2 North American Other Biomarkers Identification Technologies Market Exhibit 391. Other Biomarkers Identification Technologiesâ&#x20AC;&#x201C; North American Market Estimations and Predictions (2005-2020) in US$ Million for USA and Canada (Graphical Representation Included) Exhibit 392. Other Biomarkers Identification Technologies - North American Market Shares (2010, 2015 & 2020) for USA and Canada (Graphical Representation Included) 3.12.6.3 European Other Biomarkers Identification Technologies Market Exhibit 393. Other Biomarkers Identification Technologiesâ&#x20AC;&#x201C; European Market Estimations and Predictions (2005-2020) in US$ Million for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe (Graphical Representation Included) Exhibit 394. Other Biomarkers Identification Technologies - European Market Shares (2010, 2015 & 2020) for Germany, UK, Italy, France, Spain, Switzerland, Belgium, Sweden, Russia and Rest of Europe(Graphical Representation Included) 3.12.6.4 Asia-Pacific Other Biomarkers Identification Technologies Market Exhibit 395. Other Biomarkers Identification Technologies - Asia-Pacific Market Estimations and Predictions (2005-2020) in US$ Million for Japan, China, India, Australia, South Korea and AsiaPacific (Graphical Representation Included) Exhibit 396. Other Biomarkers Identification Technologies - Asia-Pacific Market Shares (2010, 2015 & 2020) for Japan, China, India, Australia, South Korea and Asia-Pacific (Graphical Representation Included) 3.12.6.5 Rest of World Other Biomarkers Identification Technologies Market Exhibit 397. Other Biomarkers Identification Technologies - Rest of World Market Estimations and Predictions (2005-2020) for Israel, South Africa, Brazil and Other Countries in US$ Million (Graphical Representation Included) Exhibit 398. Other Biomarkers Identification Technologies - Rest of World Market Shares (2010, 2015 & 2020) for Israel, South Africa, Brazil and Other Countries (Graphical Representation Included)

AArkstore enterprise 3.13 Biomarkers - Market Outlook

4. PRODUCT/TECHNOLOGY RESEARCH

4.1. Introduction Biomarker Groups Biomarkers of Exposure Therapeutic Biomarkers Laboratory Process of Biomarkers Development Application of Biomarkers Medical Sector Non-Medical Sector Geochemistry Astrobiology Classification of Biomarkers Classification based on applications Categorization of Biomarkers DNA Biomarkers RNA Biomarkers Gene Biomarkers Metabolic Biomarkers Cell Biomarkers

AArkstore enterprise Protein Biomarkers Biomarkers and Molecular Diagnostics Systems Biology Aim of Systems Biology Omics Technologies Based Systems Biology 4.2 Various Diseases - Role of Biomarkers Therapeutic Areas Exhibit 399. List of FDA Approved and Potential Serum Biomarkers for Various Diseases Oncology Cancer Biomarkers Application of Biomarkers in Cancer Treatment Exhibit 400. List of Cancer Biomarkers - Established and Specialized Biomarkers Established Cancer Biomarkers Specialized Cancer Biomarkers Lung Cancer Lung Cancer and Biomarkers Features of Biomarker for Lung Cancer Breast Cancer Breast Cancer Biomarkers Exhibit 401. List of Breast Cancer Biomarkers at Different Disease Stages Ovarian Cancer Ovarian Cancer Biomarkers

AArkstore enterprise Exhibit 402. List of Ovarian Cancer Biomarkers at Different Disease Stages Mass Spectrometry - An Emerging Tool for Cancer Biomarker Identification Prostate Cancer Serum Biomarkers Prostate-Specific Antigen Other Serum Biomarkers Cardiology Cardiac Biomarkers - An Overview Renal Insufficiency-Risk of Cardiovascular Disease Exhibit 403. List of Biomarkers for Various Renal Insufficiency Related Specific Diseases Established Cardiovascular Biomarkers Specialized Cardiovascular Biomarkers Exhibit 404. List of Established, Specialized and Emerging Biomarkers for Cardiovascular Diseases Congenital Heart Defects Obesity and Overweight Cardiac Rehabilitation Exhibit 405. List of Established and Specialized Hematology Biomarkers to Asses Risk for Heart Failure Exhibit 406. List of Emerging Cell Signaling Biomarkers for Prognosis & Diagnosis of Various Diseases Myocardial Infarction Exhibit 407. List of Biomarkers for Myocardial Infarction and Risk of Heart Failure Biomarkers in Diabetes

AArkstore enterprise Established Diabetes Biomarkers Specialized Diabetes Biomarkers Neurology Neurodegenerative Disorders Most Common Neurodegenerative Diseases Alzheimerâ&#x20AC;&#x2122;s Disease Diagnosis of Alzheimers Disease Parkinsonâ&#x20AC;&#x2122;s Disease Psychiatric Disorder Brain Stroke Stroke Infectious Diseases Exhibit 408. List of Infectious Diseases Biomarkers for Bacterial/Parasitic Exposure Exhibit 409. List of Infectious Diseases Biomarkers for Viral Exposure Established Biomarkers Specialized Infectious Disease Biomarkers Exhibit 410. List of Biomarkers for Gastro Intestinal Tract Infections Role of Biomarkers in Malaria Treatment Respiratory Infections Tuberculosis Biomarkers for Diagnosis of SARS Disease Role of Biomarkers in HIV Diagnosis

AArkstore enterprise Biomarkers for Chikungunya Role of Biomarkers in Sepsis Diagnosis Genetic Disorders Other Therapeutic Area Autoimmune Diseases Biomarkers for Detection of Arthritis Rheumatic Arthritis Established Osteoarthritis Biomarkers Biomarkers in Gynecology Established Autoimmune Biomarkers Specialized Autoimmune Biomarkers Established Endocrine Biomarkers Exhibit 411. List of Thyroid/Parathyroid Biomarkers Exhibit 412. List of Biomarkers for Sex Hormones Established Biomarkers Specialized Biomarkers Exhibit 413. List of Established Nutritional Biomarkers Established Hematology Biomarkers Specialized Hematology Biomarkers Established Organ Systems Biomarkers Exhibit 414. List of Liver Biomarkers Gastrointestinal

AArkstore enterprise Campylobacter Jejuni Antibody Liver Established Immune/Inflammation Biomarkers Specialized Immune/Inflammation Biomarkers Exhibit 415. List of Ageing Biomarkers and Their Effects on Human Body 4.3 Biomarker Identification Technologies Imaging Technologies Genomics Proteomics Metabolomics Gene Expression Other 4.4 Biomarkers in Drug Discovery/Development Why is Pharma/Biotech Industry Keen on Biomarkers Application and Benefits of Biomarkers in Drug Development Verification of Biomarkers Applicability Biomarkers Application in Clinical Drug Development Biomarkersâ&#x20AC;&#x2122; Effect on Discovery and Application of a Drug Drug Safety and Role of Biomarkers Exhibit 416. List of Isotope Biomarkers with Their Area of Application 4.5 Product Trends Enhanced Treatment for Spondylarthritis with Innovative Biomarkers

AArkstore enterprise A New Diagnostic Marker to Measure Efficiency of Cancer Drug SINE RNA to Emerge as Biomarker for Tobacco Hazards Kinetic Biomarker Enhances Drug Development New Biomarkers to Detect Nephrotoxicity Biomarkers in Combination with Pharmacogenomics 4.6 Biomarkers - Research Briefs Early Biomarker of Insulin Resistance and Glucose Intolerance Identified in a Non-diabetic Population SNP as Molecular Biomarkers Identification of Potential NAFLD Noninvasive Biomarkers Blood Biomarker in Association with Inflammation Cardiac Biomarker Indicates Fluid Overload in Dialysis Patients Research Identifies Novel Biomarker for Non-Small Cell Lung Carcinomas (NSCLC) Biomarkers May Offer Hope of New Osteoarthritis Test Biomarkers Found to Diagnose Chagas Disease BATTLE Identifies Potential Biomarkers Biomarker for Multiple Sclerosis Discovered by Researchers A Biomarker for the indication of lymphoma treatment The progress of biomarkers in the war against lung cancer Nanosensors to Determine Cancer Biomarkers in Blood Moreâ&#x20AC;Ś.. 5. CORPORATE DIRECTORY

AArkstore enterprise 6. PATENTS INFORMATION

Related reports:

Polyols Security Technologies in Biotechnology Biologics Bioinformatics Biosensors D-Amino Acids Lactic Acid Polylactic Acid Blood - Components, Testing & Collection Biotechnology Market Research Reports

About Aarkstore Enterprise

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

AArkstore enterprise You can order full Report with TOC and Sample page visit

http://www.aarkstore.com/biotechnology/53583/bioma rkers

Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 / 022-27564953 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com